Stockscreener 앱 받기
1,150.99
1.64%
-19.15
시장 영업 전:
1149.23
-1.76
-0.15%
Lilly Eli Co 주식(LLY)의 최신 뉴스
InnoCare and Eli Lilly strike research collaboration worth up to $3.35B - Dealroom
InnoCare Pharma partners with Eli Lilly in drug research deal - China Daily
Eli Lilly and Co. stock heads into the open after a 1.64 percent drop - AD HOC NEWS
China's InnoCare, Eli Lilly sign collaboration deal worth up to $3.35 billion - Reuters
InnoCare Announces Strategic Research Collaboration and License Agreement with Lilly to Develop New Medicines - The Manila Times
InnoCare Announces Strategic Research Collaboration and License Agreement with Lilly to Develop New Medicines - GlobeNewswire Inc.
Eli Lilly stock ends the day 1.64 percent lower - AD HOC NEWS
Lilly CEO says state needs to emphasize quality of life, health care - Inside INdiana Business
Eli Lilly & Co. stock underperforms Wednesday when compared to competitors - MarketWatch
Lilly’s Ricks says state needs to emphasize quality of life, health care - ibj.com
Eli Lilly and Co. stock gains as Houston plant expands GLP-1 capacity - AD HOC NEWS
Why is Eli Lilly (NYSE:LLY) in focus amid today’s healthcare stocks discussion? - kalkinemedia.com
Eli Lilly CEO Says Foundayo Wins One-Third of New Oral GLP-1 Patients as Company Captures 70% of New Seniors: 'Growing Week on Week' - Yahoo Finance
Eli Lilly Could Be a ‘$2,000 Stock’ in the Next 3 to 4 Years, Says Home Depot Co-Founder Ken Langone - Benzinga
How should investors read the latest signal from Eli Lilly (NYSE:LLY)? - kalkinemedia.com
Eli Lilly and Co. stock heads into the open after a 0.61 percent gain - AD HOC NEWS
Patients claim popular GLP-1 drugs led to permanent vision loss - NewsNation
Florida Sues Lilly, Sanofi, CVS in Insulin Antitrust Action (3) - Bloomberg Government News
Should Eli Lilly (LLY) Investors Watch Its $6.5 Billion Houston GLP 1 Buildout? - Yahoo Finance
Eli Lilly stock ends the day 0.61 percent higher at USD 1,172.05 - AD HOC NEWS
GLP-1 makers Novo, Eli Lilly sued over sudden loss of vision in patients - NewsNation
Novo and Lilly Challenged: Viking Stock Surges on Weight-Loss Drug Trial - Barron's
Eli Lilly Gets Full FDA Approval for Inluriyo in ESR1-Mutated Breast Cancer - Benzinga
Viking Therapeutics Stock Surges 36%+ Intraday. It Could Challenge Lilly and Novo's Obesity Empire - Moomoo
Ken Langone predicts Eli Lilly stock will hit $2,000 in 3-4 years, rivaling his Home Depot gains. - Pluang
His Bet On Home Depot Made Ken Langone A Billionaire. Now He Sees Eli Lilly Stock Hitting $2,000 - 24/7 Wall St.
Eli Lilly CEO Delivers Urgent Message on the Company's Next Big Weight-Loss Pill - Yahoo Finance
Ken Langone on Eli Lilly: Could be a $2,000 stock in the next 3-4 years - CNBC
Eli Lilly Just Got a Big Boost From Medicare's GLP-1 Expansion - TradingView
Trump's Drug Price Achievements Questioned Following Separate Most Favored Nation Contract Disclosures wi - benzinga.com
Eli Lilly stock dips despite strong earnings; C... - Pluang
Eli Lilly Breaks Ground on $6.5B GLP-1 Manufacturing Facility in Northeast Houston - REBusinessOnline
Eli Lilly CEO Says Foundayo Wins One-Third of New Oral GLP-1 Patients as Company Captures 70% of New Seni - Benzinga
Eli Lilly breaks ground on $6.5B Houston manufacturing plant - Yahoo Finance
Eli Lilly and Co. stock gains as Foundayo demand expands - AD HOC NEWS
Eli Lilly & Co (LLY) Receives a Buy from Barclays - The Globe and Mail
Eli Lilly and Co. stock rises 1.04 percent ahead of the open - AD HOC NEWS
Medicare Spurs 700K Seniors to GLP-1s; Lilly Leads - Briefs Finance
Eli Lilly breaks ground on $6B Houston manufacturing facility - cbs19.tv
Eli Lilly and Company Breaks Ground on $6.5 Billion Houston Manufacturing Site - marketscreener.com
Eli Lilly stock ends the day slightly higher at the close - AD HOC NEWS
Eli Lilly (LLY) Increases Yet Falls Behind Market: What Investors Need to Know - Yahoo Finance
Eli Lilly and Company Breaks Ground in Houston, One of Ten U.S. Manufacturing Sites Announced Since 2020 - marketscreener.com
Eli Lilly Starts Building Record $6.5B Houston Manufacturing Facility - Bisnow
Eli Lilly breaks ground on $6.5B pharmaceutical factory in Houston - houston.innovationmap.com
Eli Lilly Stock (LLY) Rises After Company Provides Update on Obesity Pill Sales - TipRanks
What Lilly Stock's Breast Cancer Drug Approval Means For Shareholders - simplywall.st
Eli Lilly (LLY) Expands Market Share with Foundayo Amid Growing Demand - GuruFocus
Eli Lilly Stock Is On Track to Do Something It Hasn't Done Since 2016 - The Motley Fool
Eli Lilly breaks ground on $6.5B Houston plant, largest project of its kind in Texas history - The Business Journals
Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs - CNBC
Eli Lilly CEO Says One-Third of New GLP-1 Pill Patients Starting on Foundayo - marketscreener.com
Eli Lilly to host groundbreaking of $6.5 billion facility at Houston’s Generation Park - CW39 Houston
Novo Nordisk Falls 7% as Post-Wegovy Growth Plan Fails to Ease Competition Fears; Eli Lilly Slips, Viking Therapeutics Edges Higher - 24/7 Wall St.
Novo says CagriSema shows greater weight loss than Lilly rival in diabetes patients - Reuters
Eli Lilly vs. Novo: The Obesity-Drug Battle Is Entering Its Next Round - Barchart.com
LLY - Finviz
Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs - Yahoo Finance
Eli Lilly and Co. stock edges higher ahead of the open after a 0.02 percent gain - AD HOC NEWS
$Eli Lilly and Co (LLY.US)$ - Moomoo
Is Eli Lilly (LLY) Trading At A Discount To Future Cash Flow? - simplywall.st
The Oral GLP-1 Tracker: Holiday takes toll on prescriptions - Fierce Pharma
Eli Lilly & Co. stock outperforms competitors on strong trading day - MarketWatch
Eli Lilly and Co Share PriceLLY, RNS News, Articles, Quotes, & Charts (NYSE:LLY) - Proactive financial news
Eli Lilly and Co Stock (LLY) Moved Up by 3.01% on Sep 14: Drivers Behind the Movement - TradingKey
Lilly completes AtaiBeckley deal, adding investigational depression pipeline - findarticles.com
Litigation Trends to Watch: Eli Lilly Comes Out Swinging in Weight Loss Cases. Plus, POWR Act Invoked - law.com
0.01%
1.01%
자본화:
|
볼륨(24시간):